BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27939960)

  • 1. Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivatives.
    Ashok P; Chander S; Chow LM; Wong IL; Singh RP; Jha PN; Sankaranarayanan M
    Bioorg Chem; 2017 Feb; 70():100-106. PubMed ID: 27939960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
    Ashok P; Chander S; Smith TK; Sankaranarayanan M
    Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.
    Ashok P; Chander S; Smith TK; Prakash Singh R; Jha PN; Sankaranarayanan M
    Bioorg Chem; 2019 Mar; 84():98-105. PubMed ID: 30500524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
    Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
    Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
    Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
    J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of 1-(thiophen-2-yl)-9H-pyrido[3,4-b]indole Derivatives as Anti-HIV-1 Agents.
    Ashok P; Lu CL; Chander S; Zheng YT; Murugesan S
    Chem Biol Drug Des; 2015 Jun; 85(6):722-8. PubMed ID: 25328020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics.
    Borsari C; Jiménez-Antón MD; Eick J; Bifeld E; Torrado JJ; Olías-Molero AI; Corral MJ; Santarem N; Baptista C; Severi L; Gul S; Wolf M; Kuzikov M; Ellinger B; Reinshagen J; Witt G; Linciano P; Tait A; Costantino L; Luciani R; Tejera Nevado P; Zander-Dinse D; Franco CH; Ferrari S; Moraes CB; Cordeiro-da-Silva A; Ponterini G; Clos J; Alunda JM; Costi MP
    Eur J Med Chem; 2019 Dec; 183():111676. PubMed ID: 31542713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indol-3-yl-thiosemicarbazone derivatives: Obtaining, evaluation of in vitro leishmanicidal activity and ultrastructural studies.
    da Silva PR; de Oliveira JF; da Silva AL; Queiroz CM; Feitosa APS; Duarte DMFA; da Silva AC; de Castro MCAB; Pereira VRA; da Silva RMF; Alves LC; Dos Santos FAB; de Lima MDCA
    Chem Biol Interact; 2020 Jan; 315():108899. PubMed ID: 31738906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-Assisted Design of Thiophene-Indole Hybrids as Leishmanial Agents.
    Félix MB; de Araújo RSA; Barros RPC; de Simone CA; Rodrigues RRL; de Lima Nunes TA; da Franca Rodrigues KA; Junior FJBM; Muratov E; Scotti L; Scotti MT
    Curr Top Med Chem; 2020; 20(19):1704-1719. PubMed ID: 32543360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
    Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
    Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Tadele M; Abay SM; Makonnen E; Hailu A
    Drug Des Devel Ther; 2020; 14():1307-1317. PubMed ID: 32280200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-leishmanial evaluation of 1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline derivatives against Leishmania infantum.
    Ashok P; Chander S; Tejería A; García-Calvo L; Balaña-Fouce R; Murugesan S
    Eur J Med Chem; 2016 Nov; 123():814-821. PubMed ID: 27541264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity and mode of action of phenolic compounds on Leishmania donovani.
    Antwi CA; Amisigo CM; Adjimani JP; Gwira TM
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007206. PubMed ID: 30802252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy.
    Mans DR; Beerens T; Magali I; Soekhoe RC; Schoone GJ; Oedairadjsingh K; Hasrat JA; van den Bogaart E; Schallig HD
    J Ethnopharmacol; 2016 Mar; 180():70-7. PubMed ID: 26778603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
    Sanderson L; Yardley V; Croft SL
    J Antimicrob Chemother; 2014 Jul; 69(7):1888-91. PubMed ID: 24668412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes.
    Pandey S; Chauhan SS; Shivahare R; Sharma A; Jaiswal S; Gupta S; Lal J; Chauhan PM
    Eur J Med Chem; 2016 Mar; 110():237-45. PubMed ID: 26840364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.